HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Testa Selected Research

monoethylglycinexylidide (L 86)

1/2003MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.
12/2001Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infection.
8/2000Histologic determinants of monoethylglycinexylidide formation in patients with chronic hepatitis C.
8/2000The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis.
7/2000Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis.
1/200013CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Testa Research Topics

Disease

10Chronic Hepatitis C
08/2006 - 06/2000
7Type 2 Diabetes Mellitus (MODY)
10/2016 - 10/2000
7Fibrosis (Cirrhosis)
08/2006 - 01/2000
6Infections
10/2016 - 10/2000
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2003 - 01/2000
4Chronic Hepatitis (Chronic Active Hepatitis)
08/2000 - 01/2000
3Cardiovascular Diseases (Cardiovascular Disease)
05/2008 - 05/2000
3Insulin Resistance
10/2007 - 10/2000
3Liver Neoplasms (Liver Cancer)
03/2004 - 07/2000
3Liver Diseases (Liver Disease)
08/2000 - 07/2000
2Diabetes Complications
04/2016 - 03/2006
2Hyperglycemia
02/2014 - 10/2000
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2010 - 10/2007
2Myocardial Infarction
01/2010 - 05/2000
2Inflammation (Inflammations)
10/2007 - 11/2001
2Coronary Disease (Coronary Heart Disease)
05/2004 - 04/2001
2Hepatocellular Carcinoma (Hepatoma)
06/2003 - 07/2000
2Disease Progression
04/2001 - 05/2000
2Cholestasis
07/2000 - 07/2000
1Pain (Aches)
01/2022
1Atrial Fibrillation
01/2018
1Muscle Spasticity (Spastic)
01/2018
1Diabetic Angiopathies (Diabetic Angiopathy)
04/2016
1Autism Spectrum Disorder
04/2014
1Thrombosis (Thrombus)
02/2014
1Hypoglycemia (Reactive Hypoglycemia)
02/2014
1Heart Failure
03/2013
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
06/2011
1Chronic Kidney Failure (Chronic Renal Failure)
01/2010
1Chronic Disease (Chronic Diseases)
05/2008
1Diabetes Mellitus
05/2008
1Atherosclerosis
03/2008
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2007
1Arthritis (Polyarthritis)
10/2007
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2005
1Colorectal Neoplasms (Colorectal Cancer)
10/2005
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
07/2003
1End Stage Liver Disease
06/2003
1Ascites
01/2003

Drug/Important Bio-Agent (IBA)

6monoethylglycinexylidide (L 86)IBA
01/2003 - 01/2000
3Glucose (Dextrose)FDA LinkGeneric
10/2016 - 10/2000
3Alanine Transaminase (SGPT)IBA
08/2006 - 06/2000
3Plasminogen InactivatorsIBA
08/2004 - 10/2000
3Glutathione Transferase (Glutathione S-Transferase)IBA
11/2001 - 06/2000
3LeptinIBA
08/2001 - 07/2000
3RNA (Ribonucleic Acid)IBA
03/2001 - 06/2000
2Pharmaceutical PreparationsIBA
01/2018 - 10/2000
2Biomarkers (Surrogate Marker)IBA
04/2016 - 04/2014
2AntioxidantsIBA
04/2016 - 05/2004
2CytokinesIBA
10/2007 - 12/2001
2Interleukin-6 (Interleukin 6)IBA
10/2007 - 03/2006
2Insulin (Novolin)FDA Link
10/2007 - 10/2000
2Aminopyrine (Aminophenazone)IBA
08/2006 - 01/2000
2EnzymesIBA
05/2004 - 10/2000
2Transaminases (Aminotransferases)IBA
03/2001 - 06/2000
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
09/2000 - 07/2000
1AnticoagulantsIBA
01/2018
1prothrombin fragment 1IBA
02/2014
1ThrombinFDA Link
02/2014
1Antithrombin IIIIBA
02/2014
1P-SelectinIBA
02/2014
1Plasminogen Activators (Plasminogen Activator)IBA
02/2014
1von Willebrand FactorIBA
02/2014
13-nitrotyrosineIBA
02/2014
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
02/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
03/2013
1Interleukin-10 (Interleukin 10)IBA
01/2010
1Urea (Carbamide)FDA LinkGeneric
01/2010
1NitrogenIBA
01/2010
1ZincIBA
05/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2008
1C-Reactive ProteinIBA
03/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2007
1LipidsIBA
10/2007
1Proteins (Proteins, Gene)FDA Link
10/2007
1Etanercept (Enbrel)FDA Link
10/2007
1Phosphotransferases (Kinase)IBA
10/2007
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2006
1Rabeprazole (Aciphex)FDA Link
01/2006
1Levofloxacin (Levaquin)FDA Link
01/2006
1TinidazoleFDA Link
01/2006
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
10/2005
1AcidsIBA
10/2005
1Plasminogen Activator Inhibitor 1IBA
08/2004
1BMY 7378IBA
07/2003
1Adrenergic alpha-1 Receptor AntagonistsIBA
07/2003
1Suramin (Suramin Sodium)IBA
07/2003
1Terazosin (Hytrin)FDA LinkGeneric
07/2003
1CreatinineIBA
01/2003
1HomocysteineIBA
03/2002

Therapy/Procedure

4Therapeutics
01/2022 - 03/2000
2Surgical Instruments (Clip)
03/2004 - 06/2003
2Liver Transplantation
01/2003 - 07/2000
1Muscle Stretching Exercises (Stretching, Static)
01/2018
1Artificial Respiration (Mechanical Ventilation)
06/2011
1Chemoprevention
10/2005
1Ligation
07/2003
1Catheters
06/2003
1Palliative Care (Palliative Therapy)
06/2003
1Aftercare (After-Treatment)
06/2003